Do you know what the most common adverse events are with the various TROP2-targeting ADCs? Through a strategic collaboration, Living Beyond Breast Cancer and Medscape/Medscape Oncology present Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs), a free, internet-based activity intended for nurses, oncology nurses, nurse practitioners (NPs), oncology NPs, pharmacists, oncology pharmacists, oncologists, and obstetrician/gynecologists. The goal of this activity is for learners to be better able to recognize and manage treatment-related adverse events (TRAEs) associated with ADCs, including novel TROP2-targeting agents. Learn more and participate: bit.ly/48kN5Qu
Living Beyond Breast Cancer
Do you know what the most common adverse events are with the various TROP2-targeting ADCs? Through a strategic collaboration, Living Beyond Breast Cancer and Medscape/Medscape Oncology present Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs), a free, internet-based activity intended for nurses, oncology nurses, nurse practitioners (NPs), oncology NPs, pharmacists, oncology pharmacists, oncologists, and obstetrician/gynecologists. The goal of this activity is for learners to be better able to recognize and manage treatment-related adverse events (TRAEs) associated with ADCs, including novel TROP2-targeting agents. Learn more and participate: bit.ly/48kN5Qu
1 year ago | [YT] | 1